Eyewear retailer Warby Parker (NYSE: WRBY) met Wall Street’s revenue expectations in Q3 2026, with sales up 10.4% year on year to $244.7 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $971 million at the midpoint. Its non-GAAP profit of $0.12 per share was 30.2% above analysts’ consensus estimates.

Is now the time to buy WRBY? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Warby Parker’s Q3 results were well received by the market, with management attributing performance to a blend of retail expansion, accelerating e-commerce, and a growing focus on eye exams and insurance services. Co-CEO Dave Gilboa emphasized the importance of “investments in our most important long-term growth initiatives” and noted that e-commerce saw its strongest growth since the company sunset its Home Try-On offering. Management also highlighted robust adoption of new product collaborations, such as its fall assortment and the launch of Warby Parker Care, its first paid protection program.

Looking ahead, management’s guidance is anchored by the upcoming launch of Intelligent Eyewear, which executives believe could fundamentally alter the company’s growth trajectory. Co-CEO Neil Blumenthal described Intelligent Eyewear as a “step function change in our business,” with a focus on driving customer engagement and expanding the addressable market. CFO Adrian Mitchell cautioned that full-year outlooks remain prudent due to unknowns around the launch and emphasized that initial revenue contribution in 2026 will be modest, with larger effects expected as production scales in the coming year.

Key insights from management’s remarks

Management identified retail footprint growth, investments in new technology, and expanded service offerings as primary factors supporting performance, while industry softness and cautious consumer behavior remain headwinds.

• Retail expansion drives accessibility: Opening 41 net new stores year-to-date, Warby Parker increased its reach and positioned itself for the Intelligent Eyewear launch. Management sees the store footprint as a key advantage for in-person product demos and customer acquisition in the new product category.
• Eye care and insurance momentum: Eye exams grew 30% year-over-year, and in-network insurance penetration reached 8.4%, both contributing to higher average revenue per customer. Management believes that investments in clinical offerings and insurance partnerships are important levers for long-term growth.
• E-commerce recovery: Online sales growth accelerated to 5% as the Home Try-On program was phased out, with management noting a high-single digit increase in online glasses and contacts order volume (excluding Home Try-On). Targeted marketing shifts supported this improvement.
• Product innovation and collaborations: Launches like the Rare Beauty and Spike Jonze collections, along with Warby Parker Sport, are resonating with new and younger customer segments. The introduction of Warby Parker Care, a paid protection plan, was met with strong early adoption.
• Operational investments and margin dynamics: Adjusted gross margin gains were driven by reduced tariffs and lab efficiencies, though higher occupancy and compensation costs, along with increased technology investments, offset some benefits. Management indicated that marketing spend would increase in Q4 to support major product launches.

Drivers of future performance

Warby Parker’s guidance is shaped by the expected impact of Intelligent Eyewear, increased marketing investments, and strategic focus on insurance and eye care services.

• Intelligent Eyewear ramp: Management expects only a modest revenue contribution in the current year due to a limited delivery window, but forecasts significant growth in 2027 as production and customer deliveries scale. Executives noted that initial focus is on customer experience and product acceptance, with the majority of sales impact to follow.
• Marketing and brand awareness: Warby Parker plans its largest campaign to date to support the Intelligent Eyewear launch, leveraging both internal and partner-funded initiatives. Management expects these campaigns to drive broader brand visibility and benefit the core business, but also acknowledged the risk of elevated expenses in the near-term.
• Insurance and clinical expansion: Ongoing efforts to increase in-network insurance usage and eye exam adoption are expected to support average revenue per customer and customer retention. Management considers further penetration in these areas a “massive opportunity” to offset softer unit growth in the broader category.

Catalysts in upcoming quarters

In the quarters ahead, our analysts will monitor (1) the pace of Intelligent Eyewear adoption and scaling of production, (2) the effectiveness of expanded marketing efforts in driving traffic and brand awareness, and (3) continued growth in insurance penetration and eye exam services. Progress on these fronts will be critical to validating Warby Parker’s strategy and sustaining momentum in a challenging retail environment.

Warby Parker currently trades at $26, up from $21.29 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

High quality stocks for all market conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.